Re: Farmas USA
ARNA
Arena Pharmaceuticals and Roivant Sciences Enter into Collaboration for Nelotanserin, a Novel Inverse Agonist of the 5-HT2A Receptor
http://www.marketwatch.com/story/arena-pharmaceuticals-and-roivant-sciences-enter-into-collaboration-for-nelotanserin-a-novel-inverse-agonist-of-the-5-ht2a-receptor-2015-05-11?reflink=MW_news_stmp